A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 1, 2008, Pages 15-22

  Vignini, Arianna ^a   Nanetti, Laura ^a   Moroni, Cinzia ^a   Testa, Roberto ^b   Sirolla, Cristina ^b   Marra, Maurizio ^b   Manfrini, Silvana ^c   Fumelli, Daniele ^b   Marcheselli, Fiorella ^b   Mazzanti, Laura ^a   Rabini, Rosa Anna ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

^c Ospedale Civile di Senigallia   (Italy)

Author keywords

Na+ K+ ATPase; Nitric oxide; Plasminogen activator inhibitor type 1; Type 2 diabetes mellitus; Vitamin E

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; ANTIOXIDANT; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; DRUG EFFECT; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; THROMBOCYTE; TIME; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

AGED; ANTIOXIDANTS; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1; VITAMIN E;

EID: 37349083093     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2007.01.002     Document Type: Article

References (44)

1. Gough S.C., and Grant P.J. The fibrinolytic system in diabetes mellitus. Diabet Med 8 10 (1991) 898-905
2. Juhan-Vague I., Alessi M.C., and Vague P. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med 28 4 (1996) 371-380
3. van Hinsbergh V.W., Kooistra T., Scheffer M.A., Hajo van Bockel J., and van Muijen G.N. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 75 7 (1990) 1490-1497
4. Schneider D.J., Nordt T.K., and Sobel B.E. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 42 1 (1993) 1-7
5. Kannel W.B., D'Agostino R.B., Wilson P.W., Belanger A.J., and Gagnon D.R. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 120 3 (1990) 672-676
6. McGill J.B., Schneider D.J., Arfken C.L., Lucore C.L., and Sobel B.E. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43 1 (1994) 104-109
7. Walmsley D., Hampton K.K., and Grant P.J. Contrasting fibrinolytic responses in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes. Diabet Med 8 10 (1991) 954-959
8. Byberg L., Siegbahn A., Berglund L., McKeigue P., Reneland R., and Lithell H. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. Arterioscler Thromb Vasc Biol 18 2 (1998) 258-264
9. Stiko-Rahm A., Wiman B., Hamsten A., and Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 10 6 (1990) 1067-1073
10. Maiello M., Boeri D., Podesta F., Cagliero E., Vichi M., Odetti P., et al. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes 41 8 (1992) 1009-1015
11. Ceriello A., Curcio F., dello Russo P., Pegoraro I., Stel G., Amstad P., et al. The defence against free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-production. Blood Coagul Fibrinolysis 6 2 (1995) 133-137
12. Oestreicher E.M., Martinez-Vasquez D., Stone J.R., Jonasson L., Roubsanthisuk W., Mukasa K., et al. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-l-arginine methyl ester-induced myocardial injury. Circulation 108 20 (2003) 2517-2523
13. Marletta M.A. Nitric oxide: Biosynthesis and biological significance. Trends Pharmacol Sci 158 (1998) 348-352
14. Michel T., and Feron O. Nitric oxide synthases: which, where, how, and why?. J Clin Invest 100 9 (1997) 2146-2152
15. Wolfsgruber W., Feil S., Brummer S., Kuppinger O., Hofmann F., and Feil R. A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells. Proc Natl Acad Sci USA 100 23 (2003) 13519-13524
16. Numano F., Kishi Y., Ashikaga T., Hata A., Makita T., and Watanabe R. What effect does controlling platelets have on atherosclerosis?. Ann NY Acad Sci 748 (1995) 383-392
17. Swiatkowska M., Cierniewska-Cieslak A., Pawlowska Z., and Cierniewski C.S. Dual regulatory effects of nitric oxide on plasminogen activator inhibitor type 1 expression in endothelial cells. Eur J Biochem 267 4 (2000) 1001-1007
18. Rabini R.A., Staffolani R., Fumelli P., Mutus B., Curatola G., and Mazzanti L. Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients. Diabetologia 41 1 (1998) 101-104
19. Krebs M., Geiger M., Polak K., Vales A., Schmetterer L., Wagner O.F., et al. Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man. Thromb Haemost 90 3 (2003) 422-428
20. Boulbou M.S., Koukoulis G.N., Makri E.D., Petinaki E.A., Gourgoulianis K.I., and Germenis A.E. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol 98 1 (2005) 39-44
21. Esterbauer H., Gebicki J., Puhl H., and Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13 (1992) 341-390
22. Bonfigli A.R., Pieri C., Manfrini S., Testa I., Sirolla C., Ricciotti R., et al. Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients. Diabetes Nutr Metab 14 2 (2001) 71-77
23. Testa R., Bonfigli A.R., Sirolla C., Boemi M., Manfrini S., Mari D., et al. Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients. Diabetes Nutr Metab 17 4 (2004) 217-221
24. Paolisso G., Tagliamonte M.R., Barbieri M., Zito G.A., Gambardella A., Varricchio G., et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. J Clin Endocrinol Metab 85 1 (2000) 109-115
25. Desideri G., Marinucci M.C., Tomassoni G., Masci P.G., Santucci A., and Ferri C. Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients. J Clin Endocrinol Metab 87 6 (2002) 2940-2945
26. Traber M.G., and Sies H. Vitamin E in humans: demand and delivery. Annu Rev Nutr 16 (1996) 321-347
27. Archer S. Measurement of nitric oxide in biological models. FASEB J 7 (1993) 349-360
28. Bradford M. A rapid and sensitive Method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
29. 2+-transport system. Biochem J 263 (1989) 547-552
30. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 66 (1925) 375-400
31. Kurowska E.M. Nitric oxide therapies in vascular diseases. Curr Pharm Des 8 3 (2002) 155-166
32. Singh U., Devaraj S., and Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 25 (2005) 151-174
33. Norata G.D., Banfi C., Pirillo A., Tremoli E., Hamsten A., Catapano A.L., et al. Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization. Br J Haematol 127 1 (2004) 97-104
34. Hou B., Eren M., Painter C.A., Covington J.W., Dixon J.D., Schoenhard J.A., et al. Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. J Biol Chem 279 18 (2004) 18127-18136
35. Murakami T., Horigome H., Tanaka K., Nakata Y., Ohkawara K., Katayama Y., et al. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res 119 1 (2007) 45-53
36. Ambring A., Johansson M., Axelsen M., Gan L., Strandvik B., and Friberg P. Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. Am J Clin Nutr 83 3 (2006) 575-581
37. Dell'Agli M., Fagnani R., Mitro N., Scurati S., Masciadri M., Mussoni L., et al. Minor components of olive oil modulate proatherogenic adhesion molecules involved in endothelial activation. J Agric Food Chem 54 9 (2006) 3259-3264
38. Giugliano D., Ceriello A., and Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 48 4 (2006) 677-685
39. Martina V., Bruno G.A., Zumpano E., Origlia C., Quaranta L., and Pescarmona G.P. Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1. J Endocrinol Invest 24 1 (2001) 37-41
40. Bouchie J.L., Hansen H., and Feener E.P. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system. Arterioscler Thromb Vasc Biol 18 11 (1998) 1771-1779
41. Das Evcimen N., Ulusu N.N., Karasu C., and Dogru B. Adnosine triphosphatase activity of streptozotocin-induced diabetic rat brain microsomes. Effect of vitamin E. Gen Physiol Biophys 23 3 (2004) 347-355
42. Cominacini L., Garbin U., Pasini A.F., Davoli A., Campagnola M., Contessi G.B., et al. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med 22 1-2 (1997) 117-127
43. Jiang M.Z., Tsukahara H., Ohshima Y., Todoroki Y., Hiraoka M., Maeda M., et al. Effects of antioxidants and nitric oxide on TNF-alpha-induced adhesion molecule expression and NF-kappaB activation in human dermal microvascular endothelial cells. Life Sci 75 10 (2004) 1159-1170
44. Beckman J.A., Goldfine A.B., Gordon M.B., Garrett L.A., Keaney Jr. J.F., and Creager M.A. Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 285 6 (2003) H2392-H2398